145 related articles for article (PubMed ID: 3035278)
1. Effect of mouse hepatitis virus infection on combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
Li LH; DeKoning TF; Nicholas JA; Kramer GD; Wilson D; Wallace TL; Collins MJ
Lab Anim Sci; 1987 Feb; 37(1):41-4. PubMed ID: 3035278
[TBL] [Abstract][Full Text] [Related]
2. Chemoimmunotherapy of B 16 melanoma and P388 leukemia with cyclophosphamide and pyrimidinones.
Li LH; Johnson MA; Moeller RB; Wallace TL
Cancer Res; 1984 Jul; 44(7):2841-7. PubMed ID: 6722813
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
Li LH; Wallace TL; Richard KA; Tracey DE
Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
[TBL] [Abstract][Full Text] [Related]
4. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
Borden EC; Sidky YA; Hatcher JF; Bryan GT
Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of pyrimidinones, a class of small-molecule biological response modifiers.
Li LH; Wallace TL; Wierenga W; Skulnick HI; DeKoning TF
J Biol Response Mod; 1987 Feb; 6(1):44-55. PubMed ID: 3559628
[TBL] [Abstract][Full Text] [Related]
6. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
Li LH; DeKoning TF; Wallace TL
Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
Li LH; Wallace TL; Hamilton RD; DeKoning TF
Int J Immunopharmacol; 1987; 9(1):31-9. PubMed ID: 3583503
[No Abstract] [Full Text] [Related]
8. Effects of cimetidine combination with cyclophosphamide in transplanted murine tumors.
Khandalekar DD; Ganu UK; Gokhale SV
Indian J Physiol Pharmacol; 1989; 33(3):171-4. PubMed ID: 2592043
[TBL] [Abstract][Full Text] [Related]
9. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
Elliott WL; Roberts BJ; Howard CT; Leopold WR
Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
[TBL] [Abstract][Full Text] [Related]
11. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
Bekesi JG; Roboz JP; Zimmerman E; Holland JF
Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclophosphamide on Friend virus leukemogenesis in virus-sensitive and virus-resistant mice.
Raikow RB; OKunewick JP; Buffo MJ; Kociban DL
Cancer Res; 1985 Feb; 45(2):555-7. PubMed ID: 3967230
[TBL] [Abstract][Full Text] [Related]
13. [Synergism of sobuzoxane in combination with doxorubicin against leukemia P388 in mice].
Dai ZQ; Xu JY; Yuan XJ; Cai JC
Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):69-71. PubMed ID: 8737460
[TBL] [Abstract][Full Text] [Related]
14. Experience with mouse hepatitis virus sanitation in three transplantable murine tumour lines.
Dagnaes-Hansen F; Horsman MR
Lab Anim; 2005 Oct; 39(4):394-9. PubMed ID: 16197706
[TBL] [Abstract][Full Text] [Related]
15. Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice.
Warzocha K; Robak T
Acta Haematol Pol; 1992; 23(1):55-62. PubMed ID: 1615753
[TBL] [Abstract][Full Text] [Related]
16. Therapy of P388 leukemia with benzaldehyde.
Balázová E; Koza I
Neoplasma; 1988; 35(6):725-8. PubMed ID: 3221939
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
Stoychkov JN; Miloushev AS
Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
[TBL] [Abstract][Full Text] [Related]
18. An improved method for analyzing survival data from combination chemotherapy experiments.
Carter WH; Stablein DM; Wampler GL
Cancer Res; 1979 Sep; 39(9):3446-53. PubMed ID: 476674
[TBL] [Abstract][Full Text] [Related]
19. Alteration of viral respiratory infections of mice by prior infection with mouse hepatitis virus.
Carrano VA; Barthold SW; Beck DS; Smith AL
Lab Anim Sci; 1984 Dec; 34(6):573-6. PubMed ID: 6097762
[TBL] [Abstract][Full Text] [Related]
20. Tissue distribution and duration of mouse hepatitis virus in naturally infected immunocompetent ICR (CD-1) and immunodeficient athymic nude-nu mouse strains used for ovarian transplantation and in vitro fertilization.
Scavizzi F; Raspa M
Lab Anim; 2004 Apr; 38(2):189-99. PubMed ID: 15070459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
